VentriPoint Diagnostics (CVE:VPT) Trading 5% Higher – Still a Buy?

VentriPoint Diagnostics Ltd. (CVE:VPT)’s share price rose 5% on Tuesday . The stock traded as high as C$0.11 and last traded at C$0.11. Approximately 243,750 shares traded hands during trading, an increase of 163% from the average daily volume of 92,791 shares. The stock had previously closed at C$0.10.

VentriPoint Diagnostics Price Performance

The stock has a market cap of C$16.50 million, a PE ratio of -3.50 and a beta of 0.39. The business has a fifty day simple moving average of C$0.11 and a two-hundred day simple moving average of C$0.15. The company has a current ratio of 0.28, a quick ratio of 6.67 and a debt-to-equity ratio of 217.41.

About VentriPoint Diagnostics

Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. It offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient’s heart chambers.